Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile
AssigneeOlatec Industries LLC
InventorsJoseph ST. LAURENT, Gerald S. JONES, David M. BRESSE
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a ω-(arylsulfonyl)alkylnitrile compound, or a pharmaceutically acceptable salt thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering an ω-(arylsulfonyl)alkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
Claims20
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a 3-(arylsulfonyl)propanenitrile compound of formula III, or a pharmaceutically acceptably salt or solvate thereof,
- wherein R4 and R5 are independently H, C1-6alkyl, C1-6alkoxy, amino, or halogen.
Dependencies are inferred from the claim text.